DOuble tasK Test On ergometeR - Basic Research on Acceptability and Use
DOKTORBRAU
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of the study is to show the concordance between the dual-task test achieved usually on an electronic treadmill and the dual-task test achieved with a cyclo-ergometer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2018
CompletedFirst Posted
Study publicly available on registry
January 11, 2019
CompletedStudy Start
First participant enrolled
August 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 17, 2022
CompletedJune 24, 2022
June 1, 2022
1.7 years
December 20, 2018
June 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Speed
Evaluate the concordance of the speed during the tests on treadmill and on cyclo-ergometer.
12 months
Speed variability
Evaluate the concordance the speed variability during the tests on treadmill and on cyclo-ergometer.
12 months
Study Arms (1)
Practice dual-task tests
EXPERIMENTALThe study consists to practice these dual-task tests with a new device which name is "Cycléo BRAU" that allows to the patients to achieve carefully an attentional task: cycle. Results will be compared tothe results obsvered during the routine GAITRITE analysis ( a validated tool for elderly patients and gait analysis).
Interventions
Eligibility Criteria
You may qualify if:
- Age ≥ 60 years old
- Patient with a near visual acuity upper or equal to 2/10
- Patient with a score of MMSE upper than 10
- Patient able to walk on a treadmill for 15 meters on straight line without help
- Patient covered by the French health insurance
- Patient (or support person or legal representative) able to understand the protocol
- Patient (or support person or legal representative) agrees to be involve in the protocol and sign the consent form
You may not qualify if:
- Patient has a wash-out period for another clinical trial
- Patient with a medical contraindication to practice bicycle
- Patient with locomotor disorders preexisting, whatever the reason
- Patient needing extern help to walk like a walking frame, rollator or tricycle
- Patient with a medical or surgical disease acute from less of 3 months
- Patient with cerebrovascular accident history or any other cerebro-medullary diseases with sensorimotor consequences
- Patient with severe depression (Geriatric Depression Scale 15 items upper than 10)
- Patient with a low proficiency of French (oral or written)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Angers
Angers, 49933, France
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre ABRAHAM, MD; PhD
University Hospital in Angers
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2018
First Posted
January 11, 2019
Study Start
August 28, 2019
Primary Completion
May 17, 2021
Study Completion
May 17, 2022
Last Updated
June 24, 2022
Record last verified: 2022-06